Flamel Seeks To Block Generic Coreg
Flamel Technologies SA hit Anchen Pharmaceuticals Inc. with a patent suit Friday, alleging the drug manufacturer infringed a patent for Flamel's heart failure drug Coreg when it submitted a bid to...To view the full article, register now.
Already a subscriber? Click here to view full article